Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: A different perspective of the host-pathogen interaction

European Journal of Immunology

Volumn 43, Issue 5, 2013, Pages 1133-1141

  Muntasell, Aura ^a   Vilches, Carlos ^b   Angulo, Ana ^c   López Botet, Miguel ^a,d  

^a HOSPITAL DEL MAR   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

CD94; Cytomegalovirus; HLA E; Human; Infection; NK cells; NKG2C

Indexed keywords

CHAPERONIN 60; HLA E ANTIGEN;

ADAPTIVE IMMUNITY; ANTIVIRAL THERAPY; CELL SURVIVAL; CHROMOSOME 12; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; DELETION MUTANT; EVOLUTIONARY ADAPTATION; FIBROBLAST; GENOTYPE; HLA SYSTEM; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE EVASION; IMMUNOCOMPROMISED PATIENT; IMMUNOPHENOTYPING; IMMUNORECEPTOR TYROSINE BASED INHIBITION MOTIF; INNATE IMMUNITY; KIDNEY TRANSPLANTATION; LYMPHOCYTOSIS; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; T LYMPHOCYTE; VIRUS INFECTION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CELL PROLIFERATION; CHILD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION; HERPESVIRIDAE INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; KILLER CELLS, NATURAL; MUROMEGALOVIRUS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; RECEPTORS, NATURAL KILLER CELL; T-LYMPHOCYTES;

EID: 84876830860     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201243117     Document Type: Review

References (90)

1. Lanier, L. L., NK cell recognition. Annu. Rev. Immunol. 2005. 23: 225-274.
2. Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R. et al., Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 2001. 19: 197-223.
3. Caligiuri, M. A., Human natural killer cells. Blood 2008. 112: 461-469.
4. Vilches, C. and Parham, P., KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol. 2002. 20: 217-251.
5. Elliott, J. M. and Yokoyama, W. M., Unifying concepts of MHC-dependent natural killer cell education. Trends Immunol. 2011. 32: 364-372.
6. Gumá, M., Angulo, A., Vilches, C., Gómez-Lozano, N., Malats, N. and López-Botet, M., Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004. 104: 3664-3671.
7. Mocarski, E. S. and Courcelle, C. T., Cytomegaloviruses and their replication. In Knipe, D. M., Howley, P. M., Griffin, D. E., and Lamb, R. A. (Eds.) Fields Virology. Lippincott Williams & Wilkins, Philadelphia 2001, pp 2629-2673.
8. Pass, R. F., Cytomegalovirus. In Knipe, D. M., Howley, P. M., Griffin, D. E. and Lamb, R. A. (Eds.) Fields Virology. Lippincott, Williams & Wilkins, Philadelphia 2001, pp 2675-2705.
9. Dowd, J. B., Aiello, A. E. and Alley, D. E., Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiol. Infect. 2009. 137: 58-65.
10. Pass, R. F., Fowler, K. B., Boppana, S. B., Britt, W. J. and Stagno, S., Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J. Clin. Virol. 2006. 35: 216-220.
11. Ludwig, A. and Hengel, H., Epidemiological impact and disease burden of congenital cytomegalovirus infection in Europe. Euro. Surveill. 2009. 14: 26-32.
12. Fishman, J. A., Infection in solid-organ transplant recipients. N. Engl. J. Med. 2007. 357: 2601-2614.
13. Romo, N., Fitó, M., Gumá, M., Sala, J., García, C., Ramos, R., Muntasell, A. et al., Association of atherosclerosis with expression of the LILRB1 receptor by human NK and T-cells supports the infectious burden hypothesis. Arterioscler. Thromb. Vasc. Biol. 2011. 31: 2314-2321.
14. Pawelec, G. and Derhovanessian, E., Role of CMV in immune senescence. Virus Res. 2011. 157: 175-179.
15. Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J. and Ploegh, H. L., Viral subversion of the immune system. Annu. Rev. Immunol. 2000. 18: 861-926.
16. Park, B., Spooner, E., Houser, B. L., Strominger, J. L. and Ploegh, H. L., The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation. J. Exp. Med. 2010. 207: 2033-2041.
17. López-Botet, M., Angulo, A. and Gumá, M., Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. Tissue Antigens 2004. 63: 195-203.
18. Wilkinson, G. W., Tomasec, P., Stanton, R. J., Armstrong, M., Prod'homme, V., Aicheler, R., McSharry, B. P. et al., Modulation of natural killer cells by human cytomegalovirus. J. Clin. Virol. 2008. 41: 206-212.
19. Jonjic, S., Polic, B. and Krmpotic, A., Viral inhibitors of NKG2D ligands: friends or foes of immune surveillance? Eur. J. Immunol. 2008. 38: 2952-2956.
20. Houchins, J. P., Yabe, T., McSherry, C. and Bach, F. H., DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J. Exp. Med. 1991. 173: 1017-1020.
21. Chang, C., Rodríguez, A., Carretero, M., López-Botet, M., Phillips, J. H. and Lanier, L. L., Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur. J. Immunol. 1995. 25: 2433-2437.
22. Lazetic, S., Chang, C., Houchins, J. P., Lanier, L. L. and Phillips, J. H., Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 1996. 157: 4741-4745.
23. Carretero, M., Cantoni, C., Bellón, T., Bottino, C., Biassoni, R., Rodríguez, A., Pérez-Villar, J. et al., The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur. J. Immunol. 1997. 27: 563-567.
24. López-Botet, M. and Bellón, T., Natural killer cell activation and inhibition by receptors for MHC class I. Curr. Opin. Immunol. 1999. 11: 301-307.
25. Lanier, L. L., Corliss, B., Wu, J. and Phillips, J. H., Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 1998. 8: 693-701.
26. Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., López-Botet, M. and Geraghty, D., HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 1998. 95: 5199-5204.
27. Braud, V. M., Allan, D. S., O'Callaghan, C. A., Soderström, K., D'Andrea, A., Ogg, G. S., Lazetic, S. et al., HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998. 391: 795-799.
28. Brooks, A. G., Borrego, F., Posch, P. E., Patamawenu, A., Scorzelli, C. J., Ulbrecht, M., Weiss, E. H. et al., Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. J. Immunol. 1999. 162: 305-313.
29. Lee, N., Goodlett, D. R., Ishitani, A., Marquardt, H. and Geraghty, D. E., HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 1998. 160: 4951-4960.
30. Braud, V. M., Allan, D. S., Wilson, D. and McMichael, A. J., TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 1998. 8: 1-10.
31. Sullivan, L. C., Clements, C. S., Rossjohn, J. and Brooks, A. G., The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity. Tissue Antigens 2008. 72: 415-424.
32. Llano, M., Lee, N., Navarro, F., García, P., Albar, J. P., Geraghty, D. E. and López-Botet, M., HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur. J. Immunol. 1998. 28: 2854-2863.
33. Valés-Gomez, M., Reyburn, H. T., Erskine, R. A., López-Botet, M. and Strominger, J. L., Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J. 1999. 18: 4250-4260.
34. Petrie, E. J., Clements, C. S., Lin, J., Sullivan, L. C., Johnson, D., Huyton, T., Heroux, A. et al., CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J. Exp. Med. 2008. 205: 725-735.
35. Vance, R. E., Kraft, J. R., Altman, J. D., Jensen, P. E. and Raulet, D. H., Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b) [In Process Citation]. J Exp Med 1998. 188: 1841-1848.
36. Vance, R. E., Jamieson, A. M. and Raulet, D. H., Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. J. Exp. Med. 1999. 190: 1801-1812.
37. Fang, M., Orr, M. T., Spee, P., Egebjerg, T., Lanier, L. L. and Sigal, L. J., CD94 is essential for NK cell-mediated resistance to a lethal viral disease. Immunity 2011. 34: 579-589.
38. Michaelsson, J., Teixeira, D. M., Achour, A., Lanier, L. L., Karre, K. and Soderström, K., A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J. Exp. Med. 2002. 196: 1403-1414.
39. Ulbrecht, M., Modrow, S., Srivastava, R., Peterson, P. A. and Weiss, E. H., Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation. J. Immunol. 1998. 160: 4375-4385.
40. Nattermann, J., Nischalke, H. D., Hofmeister, V., Ahlenstiel, G., Zimmermann, H., Leifeld, L., Weiss, E. H. et al., The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells. Am. J. Pathol. 2005. 166: 443-453.
41. Tomasec, P., Braud, V. M., Rickards, C., Powell, M. B., McSharry, B. P., Gadola, S., Cerundolo, V. et al., Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 2000. 287: 1031-1033.
42. Wang, E. C., McSharry, B., Retière, C., Tomasec, P., Williams, S., Borysiewicz, L. K., Braud, V. M. et al., UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc. Natl. Acad. Sci. USA 2002. 99: 7570-7575.
43. Ulbrecht, M., Martinozzi, S., Grzeschik, M., Hengel, H., Ellwart, J. W., Pla, M. and Weiss, E. H., Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J. Immunol. 2000. 164: 5019-5022.
44. Llano, M., Gumá, M., Ortega, M., Angulo, A. and López-Botet, M., Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets. Eur. J. Immunol. 2003. 33: 2744-2754.
45. Falk, C. S., Mach, M., Schendel, D. J., Weiss, E. H., Hilgert, I. and Hahn, G., NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation. J. Immunol. 2002. 169: 3257-3266.
46. Magri, G., Muntasell, A., Romo, N., Sáez-Borderias, A., Pende, D., Geraghty, D. E., Hengel, H. et al., NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 2011. 117: 848-856.
47. Prod'homme, V., Tomasec, P., Cunningham, C., Lemberg, M. K., Stanton, R. J., McSharry, B. P., Wang, E. C. et al., Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18. J. Immunol. 2012. 188: 2794-2804.
48. Monsivais-Urenda, A., Noyola-Cherpitel, D., Hernández-Salinas, A., García-Sepúlveda, C., Romo, N., Baranda, L., López-Botet, M. et al., Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children. Eur. J. Immunol. 2010. 40: 1418-1427.
49. Noyola, D. E., Fortuny, C., Muntasell, A., Noguera-Julián, A., Muñoz-Almagro, C., Alarcón, A., Juncosa, T. et al., Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children. Eur. J. Immunol. 2012. 42: 3256-3266.
50. Béziat, V., Liu, L., Malmberg, J. A., Ivarsson, M. A., Sohlberg, E., Bjorklund, A. T., Retière, C. et al., NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 2013. 121:2678-2688.
51. Bjorkström, N. K., Riese, P., Heuts, F., Andersson, S., Fauriat, C., Ivarsson, M. A., Bjorklund, A. T. et al., Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010. 116: 3853-3864.
52. Béziat, V., Descours, B., Parizot, C., Debré, P. and Vieillard, V., NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS One 2010. 5: e11966.
53. Vivier, E. and Anfossi, N., Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat. Rev. Immunol. 2004. 4: 190-198.
54. Sáez-Borderias, A., Romo, N., Magri, G., Gumá, M., Angulo, A. and López-Botet, M., IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C +NK cell function. J. Immunol. 2009. 182: 829-836.
55. Gumá, M., Busch, L. K., Salazar-Fontana, L. I., Bellosillo, B., Morte, C., García, P. and López-Botet, M., The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells. Eur. J. Immunol. 2005. 35: 2071-2080.
56. Meresse, B., Curran, S. A., Ciszewski, C., Orbelyan, G., Setty, M., Bhagat, G., Lee, L. et al., Reprogramming of CTLs into natural killer-like cells in celiac disease. J. Exp. Med. 2006. 203: 1343-1355.
57. Prendergast, A. J., Klenerman, P. and Goulder, P. J., The impact of differential antiviral immunity in children and adults. Nat. Rev. Immunol. 2012. 12: 636-648.
58. Miyashita, R., Tsuchiya, N., Hikami, K., Kuroki, K., Fukazawa, T., Bijl, M., Kallenberg, C. G. et al., Molecular genetic analyses of human NKG2C (KLRC2) gene deletion. Int. Immunol. 2004. 16: 163-168.
59. Moraru, M., Cisneros, E., Gómez-Lozano, N., de Pablo, R., Portero, F., Cañizares, M., Vaquero, M. et al., Host genetic factors in susceptibility to herpes simplex type 1 virus infection: contribution of polymorphic genes at the interface of innate and adaptive immunity. J. Immunol. 2012. 188: 4412-4420.
60. Thomas, R., Low, H. Z., Kniesch, K., Jacobs, R., Schmidt, R. E. and Witte, T., NKG2C deletion is a risk factor of HIV infection. AIDS Res. Hum. Retroviruses 2012. 28: 844-851.
61. Kuijpers, T. W., Baars, P. A., Dantin, C., van den Burg, M., van Lier, R. A. and Roosnek, E., Human NK cells can control CMV infection in the absence of T cells. Blood 2008. 112: 914-915.
62. López-Vergès, S., Milush, J. M., Schwartz, B. S., Pando, M. J., Jarjoura, J., York, V. A., Houchins, J. P. et al., Expansion of a unique CD57NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 2011. 108: 14725-14732.
63. Della Chiesa, M., Falco, M., Podesta, M., Locatelli, F., Moretta, L., Frassoni, F. and Moretta, A., Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? Blood 2012. 119: 399-410.
64. Foley, B., Cooley, S., Verneris, M. R., Pitt, M., Curtsinger, J., Luo, X., López-Vergès, S. et al., Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood 2012. 119: 2665-2674.
65. Bjorkström, N. K., Ljunggren, H. G. and Sandberg, J. K., CD56 negative NK cells: origin, function, and role in chronic viral disease. Trends Immunol. 2010. 31: 401-406.
66. Foley, B., Cooley, S., Verneris, M. R., Curtsinger, J., Luo, X., Waller, E. K., Anasetti, C. et al., Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen. J. Immunol. 2012. 189: 5082-5088.
67. Gumá, M., Cabrera, C., Erkizia, I., Bofill, M., Clotet, B., Ruiz, L. and López-Botet, M., Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J. Infect. Dis. 2006. 194: 38-41.
68. Mela, C. M. and Goodier, M. R., The contribution of cytomegalovirus to changes in NK cell receptor expression in HIV-1-infected individuals. J. Infect. Dis. 2007. 195: 158-159.
69. Brunetta, E., Fogli, M., Varchetta, S., Bozzo, L., Hudspeth, K. L., Marcenaro, E., Moretta, A. et al., Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection. AIDS 2010. 24: 27-34.
70. Bjorkström, N. K., Lindgren, T., Stoltz, M., Fauriat, C., Braun, M., Evander, M., Michaelsson, J. et al., Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 2011. 208: 13-21.
71. Petitdemange, C., Becquart, P., Wauquier, N., Béziat, V., Debré, P., Leroy, E. M. and Vieillard, V., Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog. 2011. 7: e1002268.
72. Béziat, V., Dalgard, O., Asselah, T., Halfon, P., Bedossa, P., Boudifa, A., Hervier, B. et al., CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur. J. Immunol. 2012. 42: 447-457.
73. Fietze, E., Prosch, S., Reinke, P., Stein, J., Docke, W. D., Staffa, G., Loning, S. et al., Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor. Transplantation 1994. 58: 675-680.
74. Söderberg-Naucler, C., Fish, K. N. and Nelson, J. A., Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J. Clin. Invest. 1997. 100: 3154-3163.
75. Brown, M. G., Dokun, A. O., Heusel, J. W., Smith, H. R., Beckman, D. L., Blattenberger, E. A., Dubbelde, C. E. et al., Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 2001. 292: 934-937.
76. Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B. and Lanier, L. L., Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002. 296: 1323-1326.
77. Smith, H. R., Heusel, J. W., Mehta, I. K., Kim, S., Dorner, B. G., Naidenko, O. V., Iizuka, K. et al., Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 2002. 99: 8826-8831.
78. Sun, J. C., Beilke, J. N. and Lanier, L. L., Adaptive immune features of natural killer cells. Nature 2009. 457: 557-561.
79. Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M. et al., Innate or adaptive immunity? The example of natural killer cells. Science 2011. 331: 44-49.
80. Sun, J. C., López-Vergès, S., Kim, C. C., DeRisi, J. L. and Lanier, L. L., NK cells and immune "memory". J. Immunol. 2011. 186: 1891-1897.
81. López-Vergès, S., Milush, J. M., Pandey, S., York, V. A., Arakawa-Hoyt, J., Pircher, H., Norris, P. J. et al., CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16 +NK-cell subset. Blood 2010. 116: 3865-3874.
82. Gumá, M., Budt, M., Sáez, A., Brckalo, T., Hengel, H., Angulo, A. and López-Botet, M., Expansion of CD94/NKG2C +NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2006. 107: 3624-3631.
83. Elmaagacli, A. H., Steckel, N. K., Koldehoff, M., Hegerfeldt, Y., Trenschel, R., Ditschkowski, M., Christoph, S. et al., Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood 2011. 118: 1402-1412.
84. Kreutzman, A., Ladell, K., Koechel, C., Gostick, E., Ekblom, M., Stenke, L., Melo, T. et al., Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation. Leukemia 2011. 25: 1587-1597.
85. Velardi, A., Ruggeri, L. and Mancusi, A., Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant. Curr. Opin. Hematol. 2012. 19: 319-323.
86. Thielens, A., Vivier, E. and Romagné, F., NK cell MHC class I specific receptors (KIR): from biology to clinical intervention. Curr. Opin. Immunol. 2012. 24: 239-245.
87. Moretta, L., Locatelli, F., Pende, D., Marcenaro, E., Mingari, M. C. and Moretta, A., Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. Blood 2011. 117: 764-771.
88. Barton, E. S., White, D. W., Cathelyn, J. S., Brett-McClellan, K. A., Engle, M., Diamond, M. S., Miller, V. L. et al., Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 2007. 447: 326-329.
89. White, D. W., Suzanne, B. R. and Barton, E. S., Immune modulation during latent herpesvirus infection. Immunol. Rev. 2012. 245: 189-208.
90. Waggoner, S. N., Cornberg, M., Selin, L. K. and Welsh, R. M., Natural killer cells act as rheostats modulating antiviral T cells. Nature 2011. 481: 394-398.